Symbol:
Als2cl
Name:
ALS2 C-terminal like
Description:
ENCODES a protein that exhibits Rab GTPase binding; identical protein binding (ortholog); INVOLVED IN protein localization; endosome organization (ortholog); ASSOCIATED WITH schizophrenia (ortholog); FOUND IN cytoplasmic vesicle; INTERACTS WITH 1,2-dichloroethane; aflatoxin B1; carbon nanotube
Type:
protein-coding
RefSeq Status:
VALIDATED
Also known as:
79H19D; 79H19E; ALS2 C-terminal-like protein; BC022645; D930044G19Rik; mFLJ00189 protein; mRn.49018
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ALS2CL (ALS2 C-terminal like) HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):
Als2cl (ALS2 C-terminal like) HGNC
Treefam, EggNOG, NCBI, OMA, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Als2cl (ALS2 C-terminal like) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
ALS2CL (ALS2 C-terminal like) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
ALS2CL (ALS2 C-terminal like) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Als2cl (ALS2 C-terminal like) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
ALS2CL (ALS2 C-terminal like) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Als2cl (ALS2 C-terminal like)
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Homo sapiens (human):
ALS2CL (ALS2 C-terminal like)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Drosophila melanogaster (fruit fly):
Als2
Alliance
DIOPT (Ensembl Compara, InParanoid, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm38 9 110,880,120 - 110,900,530 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 MGSCv37 9 110,782,678 - 110,803,034 (+) NCBI GRCm37 mm9 NCBIm37 MGSCv36 9 110,724,990 - 110,745,340 (+) NCBI mm8 Celera 9 110,606,134 - 110,626,473 (+) NCBI Celera Cytogenetic Map 9 F2 NCBI cM Map 9 60.79 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions ISO RGD:1305208 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ALS2CL mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE decreases expression ISO RGD:1305208 6480464 Topotecan results in decreased expression of ALS2CL mRNA CTD PMID:25729387 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of ALS2CL mRNA CTD PMID:28189721 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1305208 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1605837 6480464 Tetrachlorodibenzodioxin results in increased expression of ALS2CL mRNA CTD PMID:22903824 2-hydroxypropanoic acid increases expression ISO RGD:1605837 6480464 Lactic Acid results in increased expression of ALS2CL mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1605837 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ALS2CL mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1605837 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ALS2CL mRNA CTD PMID:28628672 adefovir pivoxil increases expression ISO RGD:1605837 6480464 adefovir dipivoxil results in increased expression of ALS2CL mRNA CTD PMID:25596134 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ALS2CL mRNA CTD PMID:19770486 bisphenol A decreases expression ISO RGD:1305208 6480464 bisphenol A results in decreased expression of ALS2CL mRNA CTD PMID:25181051 C60 fullerene increases expression ISO RGD:1305208 6480464 fullerene C60 results in increased expression of ALS2CL mRNA CTD PMID:19167457 calcitriol multiple interactions ISO RGD:1605837 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ALS2CL mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1605837 6480464 Calcitriol results in increased expression of ALS2CL mRNA CTD PMID:21592394 , PMID:26485663 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of ALS2CL mRNA CTD PMID:25620056 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of ALS2CL mRNA, Nanotubes, Carbon results in decreased expression of ALS2CL mRNA CTD PMID:25554681 chloroacetaldehyde affects expression ISO RGD:1605837 6480464 chloroacetaldehyde affects the expression of ALS2CL mRNA CTD PMID:25596134 chrysene increases expression EXP 6480464 chrysene results in increased expression of ALS2CL mRNA CTD PMID:26377693 cisplatin affects expression ISO RGD:1605837 6480464 Cisplatin affects the expression of ALS2CL mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:1605837 6480464 Cisplatin results in increased expression of ALS2CL mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1605837 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ALS2CL mRNA CTD PMID:27392435 clodronic acid affects expression ISO RGD:1605837 6480464 Clodronic Acid affects the expression of ALS2CL mRNA CTD PMID:25596134 cobalt dichloride increases expression ISO RGD:1305208 6480464 cobaltous chloride results in increased expression of ALS2CL mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO RGD:1605837 6480464 Copper Sulfate results in increased expression of ALS2CL mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1605837 6480464 Cyclosporine results in increased expression of ALS2CL mRNA CTD PMID:25596134 , PMID:27989131 dexamethasone multiple interactions ISO RGD:1605837 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ALS2CL mRNA CTD PMID:28628672 dioxygen decreases expression ISO RGD:1605837 6480464 Oxygen deficiency results in decreased expression of ALS2CL mRNA CTD PMID:25596134 doxorubicin decreases expression ISO RGD:1605837 6480464 Doxorubicin results in decreased expression of ALS2CL mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:1605837 6480464 Selenium results in increased expression of ALS2CL mRNA CTD PMID:19244175 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ALS2CL mRNA CTD PMID:30319688 flutamide increases expression ISO RGD:1305208 6480464 Flutamide results in increased expression of ALS2CL mRNA CTD PMID:24136188 ifosfamide affects expression ISO RGD:1605837 6480464 Ifosfamide affects the expression of ALS2CL mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:1605837 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ALS2CL mRNA CTD PMID:28628672 leflunomide increases expression ISO RGD:1305208 6480464 leflunomide results in increased expression of ALS2CL mRNA CTD PMID:24136188 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of ALS2CL mRNA CTD PMID:26307267 methapyrilene decreases expression ISO RGD:1305208 6480464 Methapyrilene results in decreased expression of ALS2CL mRNA CTD PMID:30467583 orphenadrine affects expression ISO RGD:1305208 6480464 Orphenadrine affects the expression of ALS2CL mRNA CTD PMID:23665939 oxaliplatin decreases expression ISO RGD:1305208 6480464 oxaliplatin results in decreased expression of ALS2CL mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:1305208 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ALS2CL mRNA CTD PMID:25729387 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ALS2CL mRNA CTD PMID:18301758 , PMID:18445702 rac-lactic acid increases expression ISO RGD:1605837 6480464 Lactic Acid results in increased expression of ALS2CL mRNA CTD PMID:30851411 selenium atom increases expression ISO RGD:1605837 6480464 Selenium results in increased expression of ALS2CL mRNA CTD PMID:19244175 testosterone multiple interactions ISO RGD:1605837 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ALS2CL mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1605837 6480464 Testosterone results in increased expression of ALS2CL mRNA CTD PMID:21592394 tetraphene affects expression EXP 6480464 benz(a)anthracene affects the expression of ALS2CL mRNA CTD PMID:26377693 topotecan decreases expression ISO RGD:1305208 6480464 Topotecan results in decreased expression of ALS2CL mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1305208 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ALS2CL mRNA CTD PMID:25729387 valdecoxib increases expression ISO RGD:1305208 6480464 valdecoxib results in increased expression of ALS2CL mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:1605837 6480464 Valproic Acid results in increased methylation of ALS2CL gene CTD PMID:29154799 zoledronic acid increases expression ISO RGD:1605837 6480464 zoledronic acid results in increased expression of ALS2CL mRNA CTD PMID:24714768 , PMID:25596134 
Gene-Chemical Interaction Annotations
